Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Active, currently enrolling
Who can join
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
Keywords:
Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type:
Prospective Cohort Study with Direct Patient Contact |
Region:
Georgia
Active, currently enrolling
Who can join
A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)
Keywords:
Loncastuximab Tesirine; Refractory Diffuse Large B-Cell Lymphoma; Relapsed…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, currently enrolling
Who can join
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III (S1501)
Keywords:
Oncology (Adult); S1501; Breast Neoplasms; Neoplasms; Cardiotoxicity; Neoplasms…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, not yet recruiting
Who can join
A Phase 2, Open-Label, Randomized, Global Study of Two Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Enrollment complete
Who can join
AstraZeneca ADAURA D5164C00001: A Phase III, Double-blind, Randomized, Placebo-Controlled Multi-centre, study to assess the efficacy and safety of AZD9291 versus Placebo, in Patients with Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Active, enrolling only by invitation
Who can join
A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Active, currently enrolling
Who can join
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Enrollment complete
Who can join
BO41843: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Enrollment on hold
Who can join
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
Keywords:
Stroke, Ischemic Stroke, Hemorrhagic Stroke, Cerebrovascular Disorders, Brain…
Study Type:
OBSERVATIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Keywords:
Hidradenitis Suppurativa; Hidradenitis; Acne inversa; HS; Povorcitinib;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3
4
5
6
7
8
9
10
...